Archive: 14/02/2020

Ceramides predict vascular brain injury and dementia

Novel blood-based biomarkers for dementia could identify disease at an early preclinical stage, serve as surrogate outcomes for clinical trials of investigational therapies and even identify future potential therapeutic targets. ...

page 9 from 10